IR@PKUHSC  > 北京大学第三临床医学院  > 血液内科
学科主题临床医学
Efficacy and Safety of Micafungin as Prophylaxis for Invasive Fungal Disease in Neutropenic Patients with Hematologic Malignancies
Wan, Liping1; Wang, Chun1; Liu, Lin2; Tang, Xiaoqiong2; Wang, Jinghua3; Guan, Yue3; Jiang, Ming4; Duan, Xianlin4; Ke, Xiaoyan5; Jing, Hongmei5; Hu, Jiong6; Wang, Ling6; Li, Yuming7; Geng, Li7
关键词Micafungin invasive fungal disease neutropenia hematologic malignancy prophylaxis
刊名INTERNATIONAL JOURNAL OF PHARMACOLOGY
2014-05-15
DOI10.3923/ijp.2014.231.236
10期:4页:231-236
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Pharmacology & Pharmacy
研究领域[WOS]Pharmacology & Pharmacy
关键词[WOS]STEM-CELL TRANSPLANTATION ; ANTIFUNGAL PROPHYLAXIS ; INFECTIONS ; EPIDEMIOLOGY ; FLUCONAZOLE ; REGIMENS
英文摘要

Invasive Fungal Disease (IFD) is a major cause of death in severe neutropenic patients with hematologic malignancies. Micafungin, a new echinocandin antifungal drug, is effective in treating IFD. However, the efficacy and safety of micafungin in preventing IFD in severe neutropenic patients with hematologic malignancies have not been demonstrated. A prospective and multicenter clinical study was conducted to evaluate the efficacy and safety of micafungin as prophylaxis for IFD. Micafungin 50 mg daily was administered intravenously to 117 high-risk patients with hematologic malignancies undergoing intensive chemotherapy or Hematopoietic Stem Cell Transplantation (HSCT), for a median of 24 days. Successful prophylaxis (no proven, probable or possible IFD up to 1 week after the end of prophylactic treatment) was achieved in 88.54% patients. No patient developed proven IFD during treatment and only 2.08% had probable IFD and 9.38% possible IFD. Micafungin potentially accounted for adverse events in 6.84% of patients. No severe adverse events attributable to micafungin were seen. Micafungin 50 mg daily is a promising prophylactic antifungal therapy for neutropenic patients with hematologic malignancies.

语种英语
WOS记录号WOS:000343950200006
引用统计
被引频次:2[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/61796
专题北京大学第三临床医学院_血液内科
作者单位1.Tianjin First Cent Hosp, Dept Hematol, Tianjin, Peoples R China
2.Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 1, Dept Hematol, Shanghai 200080, Peoples R China
3.Chongqing Med Univ, Affiliated Hosp 1, Dept Hematol, Chongqing, Peoples R China
4.Harbin Med Univ, Affiliated Hosp 2, Dept Hematol, Harbin, Peoples R China
5.Xinjiang Med Univ, Hematol Dis Ctr, Affiliated Hosp 1, Xinjiang, Peoples R China
6.Beijing Med Univ, Dept Hematol, Affiliated Hosp 3, Beijing 100083, Peoples R China
7.Shanghai Jiao Tong Univ, Affiliated Ruijin Hosp, Dept Hematol, Shanghai 200080, Peoples R China
推荐引用方式
GB/T 7714
Wan, Liping,Wang, Chun,Liu, Lin,et al. Efficacy and Safety of Micafungin as Prophylaxis for Invasive Fungal Disease in Neutropenic Patients with Hematologic Malignancies[J]. INTERNATIONAL JOURNAL OF PHARMACOLOGY,2014,10(4):231-236.
APA Wan, Liping.,Wang, Chun.,Liu, Lin.,Tang, Xiaoqiong.,Wang, Jinghua.,...&Geng, Li.(2014).Efficacy and Safety of Micafungin as Prophylaxis for Invasive Fungal Disease in Neutropenic Patients with Hematologic Malignancies.INTERNATIONAL JOURNAL OF PHARMACOLOGY,10(4),231-236.
MLA Wan, Liping,et al."Efficacy and Safety of Micafungin as Prophylaxis for Invasive Fungal Disease in Neutropenic Patients with Hematologic Malignancies".INTERNATIONAL JOURNAL OF PHARMACOLOGY 10.4(2014):231-236.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Wan, Liping]的文章
[Wang, Chun]的文章
[Liu, Lin]的文章
百度学术
百度学术中相似的文章
[Wan, Liping]的文章
[Wang, Chun]的文章
[Liu, Lin]的文章
必应学术
必应学术中相似的文章
[Wan, Liping]的文章
[Wang, Chun]的文章
[Liu, Lin]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。